|Dr. Robert Brookins B.A., B.Sc., Ph.D.||CEO, MD & Director||349.12k||N/A||N/A|
|Mr. Jason Lewis||Chief Financial Officer||295.89k||N/A||N/A|
|Mr. Mark Wise||VP of Investor Relations & Corp. Communications||N/A||N/A||N/A|
|Ms. Maja Aleksandra McGuire||Gen. Counsel||N/A||N/A||N/A|
|Mr. Scott Hunter||VP of Sales||N/A||N/A||N/A|
|Ms. Jessica Hutchison||VP of HR||N/A||N/A||N/A|
|Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, GAICD, GradDip CSP, FGIA||Company Sec.||N/A||N/A||1964|
Alexium International Group Limited develops and sells specialty chemicals and solutions in Australia, the United States, and Cyprus. It offers flame retardant (FR) treatments, including Alexiflam FR for use in synthetic and synthetic-blend fabrics; Alexiflam NF for use in cotton and cotton-blends; and Alexicool, a chemical finish for fabrics. Its products are used in defense applications; and consumer applications, such as automotive and transportation, and bedding. The company is based in Greer, South Carolina.
Alexium International Group Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.